Antibody-mediated therapies have evolved as a mainstay of targeted anti-cancer therapy but also of auto-immune and other diseases. Scientists at the University of Göttingen identified new compounds to boost efficacy of antibody therapies.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
